Loading...

Michael Chan, MD

TitleClinical Fellow
InstitutionUniversity of California San Francisco
DepartmentRadiology
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Chen HJ, Huang RL, Liew PL, Su PH, Chen LY, Weng YC, Chang CC, Wang YC, Chan M, Lai HC. GATA3 as a master regulator and therapeutic target in ovarian high-grade serous carcinoma stem cells. Int J Cancer. 2018 Jul 14. PMID: 30006927.
      View in: PubMed
    2. Chiu HF, Chan M, Cheng CY, Chou JL, Lin JM, Yang YL, Lu KT. Neonatal Dexamethasone Treatment Suppresses Hippocampal Estrogen Receptor a Expression in Adolescent Female Rats. Mol Neurobiol. 2018 Jul 13. PMID: 30006761.
      View in: PubMed
    3. Chen KW, Chang YJ, Yeh CM, Lian YL, Chan M, Kao CF, Chen L. SH2B1 modulates chromatin state and MyoD occupancy to enhance expressions of myogenic genes. Biochim Biophys Acta. 2017 02; 1860(2):270-281. PMID: 28039048.
      View in: PubMed
    4. Yeh CM, Chang LY, Lin SH, Chou JL, Hsieh HY, Zeng LH, Chuang SY, Wang HW, Dittner C, Lin CY, Lin JM, Huang YT, Ng EK, Cheng AS, Wu SF, Lin J, Yeh KT, Chan M. Epigenetic silencing of the NR4A3 tumor suppressor, by aberrant JAK/STAT signaling, predicts prognosis in gastric cancer. Sci Rep. 2016 08 16; 6:31690. PMID: 27528092.
      View in: PubMed
    5. Lin YH, Hung SK, Chiou WY, Lee MS, Shen BJ, Chen LC, Liu DW, Tsai WT, Lin PH, Shih YT, Hsu FC, Tsai SJ, Chan M, Lin HY. Significant symptoms alleviation and tumor volume reduction after combined simultaneously integrated inner-escalated boost and volumetric-modulated arc radiotherapy in a patient with unresectable bulky hepatocellular carcinoma: A care-compliant case report. Medicine (Baltimore). 2016 Aug; 95(34):e4717. PMID: 27559982.
      View in: PubMed
    6. Hsieh HY, Shen CH, Lin RI, Feng YM, Huang SY, Wang YH, Wu SF, Hsu CD, Chan M. Cyproheptadine exhibits antitumor activity in urothelial carcinoma cells by targeting GSK3ß to suppress mTOR and ß-catenin signaling pathways. Cancer Lett. 2016 Jan 01; 370(1):56-65. PMID: 26454215.
      View in: PubMed
    7. Yeh CM, Chen PC, Hsieh HY, Jou YC, Lin CT, Tsai MH, Huang WY, Wang YT, Lin RI, Chen SS, Tung CL, Wu SF, Chang DC, Shen CH, Hsu CD, Chan M. Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma. Oncotarget. 2015 Oct 06; 6(30):29555-72. PMID: 26320192; PMCID: PMC4745746.
    8. Lin HY, Hung SK, Lee MS, Chiou WY, Huang TT, Tseng CE, Shih LY, Lin RI, Lin JM, Lai YH, Chang CB, Hsu FC, Chen LC, Tsai SJ, Su YC, Li SC, Lai HC, Hsu WL, Liu DW, Tai CK, Wu SF, Chan M. DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating study. Oncotarget. 2015 Jan 20; 6(2):915-34. PMID: 25460508; PMCID: PMC4359265.
    9. Chou JL, Huang RL, Shay J, Chen LY, Lin SJ, Yan PS, Chao WT, Lai YH, Lai YL, Chao TK, Lee CI, Tai CK, Wu SF, Nephew KP, Huang TH, Lai HC, Chan M. Hypermethylation of the TGF-ß target, ABCA1 is associated with poor prognosis in ovarian cancer patients. Clin Epigenetics. 2015; 7:1. PMID: 25628764; PMCID: PMC4307187.
    10. Lin HY, Huang TH, Chan M. Aberrant epigenetic modifications in radiation-resistant head and neck cancers. Methods Mol Biol. 2015; 1238:321-32. PMID: 25421668.
      View in: PubMed
    11. Cheng FH, Aguda BD, Tsai JC, Kochanczyk M, Lin JM, Chen GC, Lai HC, Nephew KP, Hwang TW, Chan M. A mathematical model of bimodal epigenetic control of miR-193a in ovarian cancer stem cells. PLoS One. 2014; 9(12):e116050. PMID: 25545504; PMCID: PMC4278842.
    12. Lu KT, Huang TC, Wang JY, You YS, Chou JL, Chan M, Wo PY, Amstislavskaya TG, Tikhonova MA, Yang YL. NKCC1 mediates traumatic brain injury-induced hippocampal neurogenesis through CREB phosphorylation and HIF-1a expression. Pflugers Arch. 2015 Aug; 467(8):1651-61. PMID: 25201604.
      View in: PubMed
    13. Yeh CM, Shay J, Zeng TC, Chou JL, Huang TH, Lai HC, Chan M. Epigenetic silencing of ARNTL, a circadian gene and potential tumor suppressor in ovarian cancer. Int J Oncol. 2014 Nov; 45(5):2101-7. PMID: 25175925.
      View in: PubMed
    14. Chan M, Chang CB, Tung CH, Sun J, Suen JL, Wu SF. Low-dose 5-aza-2'-deoxycytidine pretreatment inhibits experimental autoimmune encephalomyelitis by induction of regulatory T cells. Mol Med. 2014 Jun 26; 20:248-56. PMID: 24869907; PMCID: PMC4107100.
    15. Wang HH, Wu MM, Chan M, Pu YS, Chen CJ, Lee TC. Long-term low-dose exposure of human urothelial cells to sodium arsenite activates lipocalin-2 via promoter hypomethylation. Arch Toxicol. 2014 Aug; 88(8):1549-59. PMID: 24570342.
      View in: PubMed
    16. Lai NS, Chou JL, Chen GC, Liu SQ, Lu MC, Chan M. Association between cytokines and methylation of SOCS-1 in serum of patients with ankylosing spondylitis. Mol Biol Rep. 2014 Jun; 41(6):3773-80. PMID: 24532142.
      View in: PubMed
    17. Liao YP, Chen LY, Huang RL, Su PH, Chan M, Chang CC, Yu MH, Wang PH, Yen MS, Nephew KP, Lai HC. Hypomethylation signature of tumor-initiating cells predicts poor prognosis of ovarian cancer patients. Hum Mol Genet. 2014 Apr 01; 23(7):1894-906. PMID: 24256813; PMCID: PMC3943526.
    18. Tseng KC, Chou JL, Huang HB, Tseng CW, Wu SF, Chan M. SOCS-1 promoter methylation and treatment response in chronic hepatitis C patients receiving pegylated-interferon/ribavirin. J Clin Immunol. 2013 Aug; 33(6):1110-6. PMID: 23702664.
      View in: PubMed
    19. Lin HY, Huang TT, Lee MS, Hung SK, Lin RI, Tseng CE, Chang SM, Chiou WY, Hsu FC, Hsu WL, Liu DW, Su YC, Li SC, Chan M. Unexpected close surgical margin in resected buccal cancer: very close margin and DAPK promoter hypermethylation predict poor clinical outcomes. Oral Oncol. 2013 Apr; 49(4):336-44. PMID: 23245584.
      View in: PubMed
    20. Rodriguez BA, Frankhouser D, Murphy M, Trimarchi M, Tam HH, Curfman J, Huang R, Chan M, Lai HC, Parikh D, Ball B, Schwind S, Blum W, Marcucci G, Yan P, Bundschuh R. Methods for high-throughput MethylCap-Seq data analysis. BMC Genomics. 2012; 13 Suppl 6:S14. PMID: 23134780; PMCID: PMC3481483.
    21. Cheng AS, Li MS, Kang W, Cheng VY, Chou JL, Lau SS, Go MY, Lee CC, Ling TK, Ng EK, Yu J, Huang TH, To KF, Chan M, Sung JJ, Chan FK. Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis. Gastroenterology. 2013 Jan; 144(1):122-133.e9. PMID: 23058321.
      View in: PubMed
    22. Yo YT, Lin YW, Wang YC, Balch C, Huang RL, Chan M, Sytwu HK, Chen CK, Chang CC, Nephew KP, Huang T, Yu MH, Lai HC. Growth inhibition of ovarian tumor-initiating cells by niclosamide. Mol Cancer Ther. 2012 Aug; 11(8):1703-12. PMID: 22576131.
      View in: PubMed
    23. Kennedy BA, Deatherage DE, Gu F, Tang B, Chan M, Nephew KP, Huang TH, Jin VX. ChIP-seq defined genome-wide map of TGFß/SMAD4 targets: implications with clinical outcome of ovarian cancer. PLoS One. 2011; 6(7):e22606. PMID: 21799915; PMCID: PMC3143154.
    24. Yeh KT, Chen TH, Yang HW, Chou JL, Chen LY, Yeh CM, Chen YH, Lin RI, Su HY, Chen GC, Deatherage DE, Huang YW, Yan PS, Lin HJ, Nephew KP, Huang TH, Lai HC, Chan M. Aberrant TGFß/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer. Epigenetics. 2011 Jun; 6(6):727-39. PMID: 21540640; PMCID: PMC3359493.
    25. Chou JL, Chen LY, Lai HC, Chan M. TGF-ß: friend or foe? The role of TGF-ß/SMAD signaling in epigenetic silencing of ovarian cancer and its implication in epigenetic therapy. Expert Opin Ther Targets. 2010 Nov; 14(11):1213-23. PMID: 20925461.
      View in: PubMed
    26. Chou JL, Su HY, Chen LY, Liao YP, Hartman-Frey C, Lai YH, Yang HW, Deatherage DE, Kuo CT, Huang YW, Yan PS, Hsiao SH, Tai CK, Lin HJ, Davuluri RV, Chao TK, Nephew KP, Huang TH, Lai HC, Chan M. Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer. Lab Invest. 2010 Mar; 90(3):414-25. PMID: 20065949; PMCID: PMC2829100.
    27. Huang YW, Jansen RA, Fabbri E, Potter D, Liyanarachchi S, Chan M, Liu JC, Crijns AP, Brown R, Nephew KP, van der Zee AG, Cohn DE, Yan PS, Huang TH, Lin HJ. Identification of candidate epigenetic biomarkers for ovarian cancer detection. Oncol Rep. 2009 Oct; 22(4):853-61. PMID: 19724865; PMCID: PMC2829240.
    28. Qin H, Chan M, Liyanarachchi S, Balch C, Potter D, Souriraj IJ, Cheng AS, Agosto-Perez FJ, Nikonova EV, Yan PS, Lin HJ, Nephew KP, Saltz JH, Showe LC, Huang TH, Davuluri RV. An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules. BMC Syst Biol. 2009 Jul 17; 3:73. PMID: 19615063; PMCID: PMC2724489.
    29. Studebaker AW, Storci G, Werbeck JL, Sansone P, Sasser AK, Tavolari S, Huang T, Chan M, Marini FC, Rosol TJ, Bonafé M, Hall BM. Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. Cancer Res. 2008 Nov 01; 68(21):9087-95. PMID: 18974155.
      View in: PubMed
    30. Lai HC, Lin YW, Huang TH, Yan P, Huang RL, Wang HC, Liu J, Chan M, Chu TY, Sun CA, Chang CC, Yu MH. Identification of novel DNA methylation markers in cervical cancer. Int J Cancer. 2008 Jul 01; 123(1):161-7. PMID: 18398837.
      View in: PubMed
    31. Zhang S, Balch C, Chan M, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH, Nephew KP. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 2008 Jun 01; 68(11):4311-20. PMID: 18519691; PMCID: PMC2553722.
    32. Cheng AS, Culhane AC, Chan M, Venkataramu CR, Ehrich M, Nasir A, Rodriguez BA, Liu J, Yan PS, Quackenbush J, Nephew KP, Yeatman TJ, Huang TH. Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome. Cancer Res. 2008 Mar 15; 68(6):1786-96. PMID: 18339859; PMCID: PMC4172329.
    33. Zuo T, Wang L, Morrison C, Chang X, Zhang H, Li W, Liu Y, Wang Y, Liu X, Chan M, Liu JQ, Love R, Liu CG, Godfrey V, Shen R, Huang TH, Yang T, Park BK, Wang CY, Zheng P, Liu Y. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell. 2007 Jun 29; 129(7):1275-86. PMID: 17570480; PMCID: PMC1974845.
    34. Cheng AS, Jin VX, Fan M, Smith LT, Liyanarachchi S, Yan PS, Leu YW, Chan M, Plass C, Nephew KP, Davuluri RV, Huang TH. Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters. Mol Cell. 2006 Feb 03; 21(3):393-404. PMID: 16455494.
      View in: PubMed
    35. Chan M, Wei SH, Wen P, Wang Z, Matei DE, Liu JC, Liyanarachchi S, Brown R, Nephew KP, Yan PS, Huang TH. Hypermethylation of 18S and 28S ribosomal DNAs predicts progression-free survival in patients with ovarian cancer. Clin Cancer Res. 2005 Oct 15; 11(20):7376-83. PMID: 16243810.
      View in: PubMed
    36. Bai AH, Tong JH, To KF, Chan M, Man EP, Lo KW, Lee JF, Sung JJ, Leung WK. Promoter hypermethylation of tumor-related genes in the progression of colorectal neoplasia. Int J Cancer. 2004 Dec 10; 112(5):846-53. PMID: 15386372.
      View in: PubMed
    37. Yu MY, Tong JH, Chan PK, Lee TL, Chan M, Chan AW, Lo KW, To KF. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers. Int J Cancer. 2003 Jun 10; 105(2):204-9. PMID: 12673680.
      View in: PubMed
    38. Chan M, Chan LW, Tang NL, Lo KW, Tong JH, Chan AW, Cheung HY, Wong WS, Chan PS, Lai FM, To KF. Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients. Int J Cancer. 2003 May 01; 104(5):611-6. PMID: 12594816.
      View in: PubMed
    39. To KF, Leung WK, Lee TL, Yu J, Tong JH, Chan M, Ng EK, Chung SC, Sung JJ. Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int J Cancer. 2002 Dec 20; 102(6):623-8. PMID: 12448005.
      View in: PubMed